Long-term continuation on cardiovascular drug treatment in patients with coronary heart disease

Annals of Pharmacotherapy

Volumn 41, Issue 10, 2007, Pages 1644-1647

  Wald, David S ^a   Morton, Geraint ^b   Walker, Kate ^c   Losson, Neil ^b   Curzen, Nick P ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^c Institute of Preventive Medicine   (India)

Author keywords

Adherence; Cardiovascular drugs

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIAZIDE DIURETIC AGENT;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CHRONIC DRUG ADMINISTRATION; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROPHYLAXIS; TREATMENT DURATION;

CARDIOVASCULAR AGENTS; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT DISCHARGE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TIME;

EID: 34748884879     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1K232     Document Type: Article

References (10)

1. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003;326:1419-24.
2. Dunbar-Jacon J, Mortimer-Stephens MK. Treatment adherence in chronic disease. J Clin Epidemiol 2001;54(suppl 1):57-60.
3. Srinath Reddy K. The preventive polypill - much promise, insufficient evidence. N Engl J Med 2007;356:212.
4. Kulkarni SP, Alexander KP, Lytle B, Heiss G, Peterson ED. Long term adherence with cardiovascular drug regimens. Am Heart J 2006;151:185-91.
5. Simpson E, Beck C, Richard H, Eisenberg MJ, Pilote L. Drug prescriptions after acute myocardial infarction; dosage, compliance and persistence. Am Heart J 2003;145:438-44.
6. Law MR, Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ 2003;326:1427-34.
7. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 2003;326:1423-7.
8. Hippisley-Cox J, Coupland C. Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis. BMJ 2005;330:1059-63.
9. Gaede P, Vedel P, Larsen N, Jensen GVH, Parving H-H, Pederson O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348:383-93.
10. Law MR, Watt HC, Wald NJ. The underlying risk of death after myocardial infarction in the absence of treatment. Arch Intern Med 2002;162: 2405-10.